Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This article discusses the use of mesotherapy in dentistry and reports no new clinical results, emphasizing the need for further research on its applications for oral problems.

Dutasteride and minoxidil mesotherapy effectively treats hair loss with minimal side effects.

Mesotherapy can cause serious side effects like infections and skin reactions.

Mesotherapy is a minimally invasive treatment with potential benefits and risks, requiring standardized practices and further investigation.

This study found that using minoxidil 2% as a mesotherapy injection showed more significant improvement in treating androgenetic alopecia in female patients than topical application.

In this case report, a 31-year-old man with frontal hairline recession saw a marked improvement in hair density and scalp appearance after undergoing six mesotherapy sessions alongside twice-daily application of 5% minoxidil, attributed to the treatment protocol combining nutrients, bioactives, and topical minoxidil.

This study evaluated the efficacy and safety of microneedling combined with mesotherapy for androgenic alopecia and found that combination protocols, particularly those including both finasteride and latanoprost, showed the highest efficacy, especially among women and younger participants.

This study reports that perioperative use of dutasteride, both orally and through mesotherapy, may enhance hair graft survival and reduce shock loss in patients undergoing hair transplantation for androgenetic alopecia.

This study investigated the effects of mesotherapy on alopecia in patients who had bariatric surgery, highlighting significant roles of individual, behavioral, and structural factors, though specific results were not fully detailed in the abstract.

This study reviewed existing literature on mesotherapy as a treatment for androgenetic alopecia, finding that it may improve hair density and thickness with generally mild side effects, but emphasized variability in study designs limits the strength of these conclusions.

In this series, patients experienced alopecia with limited regrowth following mesotherapy, indicating possible lasting aesthetic consequences and suggesting the need for careful technique and close follow-up, as the condition might be underrecognized.

This study found that in patients with female androgenetic alopecia, mesodermal injection of 0.5% minoxidil was more effective in increasing hair density and improving hairline height than topical 2% minoxidil, with comparable safety over 16 weeks.

This study found that mesotherapy with placenta polypeptide injection significantly reduced skin inflammation and improved aesthetic outcomes in adults with moderate-to-severe sensitive skin, without increasing adverse events compared to controls.

This study found that eyebrow mesotherapy with a growth factor-based serum improved eyebrow width, length, density, and psychosocial outcomes such as social engagement, quality of life, confidence, and mood in individuals with sparse or weakened eyebrows.

This case report suggests that combining platelet-rich plasma therapy with mesotherapy may effectively increase hair density and improve scalp health in complex cases of androgenetic alopecia.

This study found that combining oral minoxidil, oral dutasteride, and dutasteride mesotherapy was the most effective treatment for androgenetic alopecia, with improved outcomes at 12 months and a favorable safety profile, compared to other treatment combinations.

In this review, the authors assessed the efficacy of mesotherapy for alopecia treatment, finding that combining mesotherapy with minoxidil, PRP, or growth factors significantly improves hair density and thickness but noted the need for standardized protocols and larger studies to confirm long-term effectiveness.

This review found that mesotherapy could improve hair density and reduce hair fall in androgenetic alopecia, especially when combined with other treatments, but lacks standardized protocols and long-term safety data.

In this report, four cases of noncicatricial alopecia developed following a single session of dutasteride mesotherapy in patients with androgenetic alopecia, highlighting potential adverse effects and the need for careful monitoring of the drug's composition.

This review examines the diverse uses of mesotherapy in dermatology, noting its efficacy in enhancing skin hydration and treating conditions such as hyperpigmentation, hair loss, and acne scarring, while highlighting its potential to optimize overall skin health.

This study evaluated eyebrow mesotherapy with a growth factor-based cocktail in 32 women with thin eyebrows, finding high satisfaction rates (90.6%) with significant improvements in density and appearance, low pain levels, and unanimous willingness to recommend the treatment.

In this retrospective analysis, dutasteride mesotherapy was used in 10 patients with androgenetic alopecia and resulted in hair density and width changes measured at the scalp, but specific efficacy results are not detailed in the abstract.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

In this clinical trial, 16 women with frontal fibrosing alopecia experienced significant improvements in hair density, vellus hair count, and quality of life after monthly intralesional dutasteride treatments, though larger and longer-term studies are needed to confirm these findings.

This study found that combining Bioscalp with Ultra Exo Booster and Ultra S Line Plus significantly promoted hair growth and maintained hair bulb integrity in cultured hair follicles from Korean adults.

In this study, injections of PRP and MZT products significantly improved hair thickness, density, and count in AGA patients over six months, with variability observed in the extent of improvement between different formulations.

This study found that mesotherapy combined with minoxidil for androgenetic alopecia shows promise with high patient satisfaction and manageable risks, though some uncommon side effects may occur.

This study clarifies the fundamental aspects of intradermotherapy or mesotherapy, tracing its historical development and highlighting its benefits as well as the negative consequences of improper use, specifically addressing its decline due to severe side effects from treatment errors.

In this study, researchers found that adding zygomaticotemporal nerve blocks to supratrochlear and supraorbital nerve blocks in mesotherapy lowered pain significantly during and after the procedure for hair regrowth in alopecia patients.

Dutasteride injections can help treat hair loss in men and women.